Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/CE

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/CE(x) 2.651.973.003.432.31

What is the latest EV/CE ratio of NATCO PHARMA ?

The latest EV/CE ratio of NATCO PHARMA is 2.65 based on Mar2024 Consolidated results.
Year EV/CE
Mar20242.65
Mar20231.97
Mar20223.00
Mar20213.43
Mar20202.31

How is EV/CE of NATCO PHARMA Trending?

Years EV/CE % Change
Mar2024 2.65
34.52
Mar2023 1.97
-34.33
Mar2022 3
-12.54
Mar2021 3.43
48.48
Mar2020 2.31 -

Other Financial Ratios of NATCO PHARMA


Compare EV/CE ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,808.9 Cr 10.7% 5.9% -15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

5.9%

-15.1%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses